Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BCBA/GILDD stock hub

BCBA/GILDD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/GILDDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

227.1T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/GILDD

In the news

Latest news · BCBA/GILDD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E17.8

P25 n/aP50 n/aP75 n/a

ROE43.4

P25 n/aP50 n/aP75 n/a

ROIC27.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/GILDD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	17,000
Employees Change	-600%
Employees Change Percent	-3.41
Enterprise value	$242.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$227.1T
Price	$34.6
Price currency	USD
Rev Per Employee	2,416,511,257.84x
Sic	2836
Symbol	bcba/GILDD
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.61%
EV Earnings	19.07x
EV/EBIT	14.55x
EV/EBITDA	11.7x
EV/FCF	17.18x
EV/Sales	5.86x
FCF yield	6.22%
P/B ratio	7.02x
P/E ratio	17.84x
P/S ratio	5.53x
PE Ratio10 Y	73.41x
PE Ratio3 Y	123.96x
PE Ratio5 Y	81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.3%
EBITDA Margin	49.56%
FCF margin	34.4%
Gross margin	79.37%
Gross Profit	$32.6T
Gross Profit Growth	4.91%
Gross Profit Growth Q	7.57%
Gross Profit Growth3 Y	3.3%
Gross Profit Growth5 Y	1.9%
Net Income	$12.7T
Net Income Growth	54.5%
Net Income Growth Q	53.69%
Net Income Growth3 Y	18.18%
Net Income Growth5 Y	98.24%
Pretax Margin	36.07%
Profit Margin	30.99%
Profit Per Employee	$748.9M
ROA	13.29
Roa5y	10.85
ROCE	25.61
ROE	43.36
Roe5y	24.33
ROIC	27.7
Roic5y	21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	54.99%
Cagr3y	18.17%
Cagr5y	15.06%
Div CAGR3	111.02%
EPS Growth	55.43
EPS Growth Q	54.81
EPS Growth3 Y	18.49
EPS Growth5 Y	98.31
FCF Growth	3.92%
FCF Growth Q	46.82%
FCF Growth3 Y	6.85%
FCF Growth5 Y	3.3%
OCF Growth	4.25%
OCF Growth Q	44.79%
OCF Growth10 Y	-5.37%
OCF Growth3 Y	6.38%
OCF Growth5 Y	2.95%
Revenue Growth	3.48x
Revenue Growth Q	4.4x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.53
Assets	$77.7T
Cash	$13.6T
Current Assets	$26.1T
Current Liabilities	$13.3T
Debt	$30.6T
Debt EBITDA	$1.49
Debt Equity	$0.95
Debt FCF	$2.17
Equity	$32.4T
Interest Coverage	11.94
Liabilities	$45.4T
Long Term Assets	$51.7T
Long Term Liabilities	$32.1T
Net Cash	$-15.7T
Net Cash By Market Cap	$-6.92
Net Debt EBITDA	$0.77
Net Debt Equity	$0.49
Net Debt FCF	$1.11
Tangible Book Value	$-1.6T
Tangible Book Value Per Share	$-1,314

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	3.34
Net Working Capital	$913.2B
Quick ratio	1.54
Working Capital	$12.7T
Working Capital Turnover	$5,988

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	43.11%
Dividend Growth Years	5%
Dividend per share	$692
Dividend Years	6
Dividend Yield	2,000.3%
Ex Div Date	2026-03-13
Last Dividend	$181
Payout Frequency	Quarterly
Payout Ratio	43.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	54.95%
200-day SMA	31.04
3Y total return	65.03%
50-day SMA	36.53
50-day SMA vs 200-day SMA	50over200
5Y total return	101.59%
All Time High	1,432.5
All Time High Change	-97.58%
All Time High Date	2020-03-05
All Time Low	14.5
All Time Low Change	138.62%
All Time Low Date	2022-04-25
ATR	1.09
Ch YTD	10.61
High	35.06
High52	40.41
High52 Date	2026-02-26
High52ch	-14.38%
Low	33.51
Low52	25.2
Low52 Date	2025-07-21
Low52ch	37.3%
Ma50ch	-5.29%
Price vs 200-day SMA	11.46%
RSI	46.28
RSI Monthly	35.67
RSI Weekly	55.03
Sharpe ratio	1.14x
Sortino ratio	1.8
Total Return	2,000.64%
Tr YTD	11.23
Tr1m	-11.28%
Tr1w	-0.14%
Tr3m	-12.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$16.6T
Operating Income Growth	9.44
Operating Income Growth Q	6.55
Operating Income Growth3 Y	5.45
Operating Income Growth5 Y	0.53
Operating margin	40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,239,252,307%
Net Borrowing	-3,905,052,904,264
Shares Insiders	0.1%
Shares Institutions	88.48%
Shares Qo Q	0.08%
Shares Yo Y	-0.34%
Short Ratio	3.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$12.9T
Average Volume	67.05x
Bv Per Share	26,156.4
CAPEX	$-795.8B
Ch1m	-11.28
Ch1w	-0.14
Ch1y	52.09
Ch3m	-12.74
Ch3y	54.81
Ch5y	82.11
Ch6m	19.31
Change	-3.08%
Change From Open	-1.31
Close	35.7
Days Gap	-1.79
Depreciation Amortization	3,850,505,245,501
Dollar Volume	11,210.4
Earnings Date	2026-05-07
EBIT	$16.6T
EBITDA	$20.4T
EPS	$10,158
F Score	8
FCF	$14.1T
FCF EV Yield	5.82x
Financing CF	-11,822,994,244,600
Fiscal Year End	December
Founded	1,987
Goodwill	11,628,441,921,938
Graham Number	14.67224
Graham Upside	-57.59
Income Tax	$2.1T
Investing CF	-3,602,987,729,600
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	$48.5
Lynch Upside	40.17
Ma150	32.31
Ma150ch	7.1%
Ma20	35.16
Ma20ch	-1.6%
Net CF	-410,309,568,900
Next Earnings Date	2026-08-06
Open	35.06
P FCF Ratio	16.07
P OCF Ratio	15.21
Payment Date	2026-03-30
Position In Range	70.32
Ppne	7,885,633,336,046
Price Date	2026-05-08
Price EBITDA	$11.15
Relative Volume	4.83x
Revenue	41,080,691,383,200x
SBC By Revenue	3.04x
Share Based Comp	1,247,506,871,100
Tax By Revenue	5.08x
Tax Rate	14.09%
Tr6m	20.48%
Volume	324
Z Score	4.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/GILDD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2000.3%

$692 annual per share

Payout ratio

+43.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

5 consecutive years of growth

Total shareholder yield

+2000.6%

Next ex-dividend date: 2026-03-13

Performance

BCBA/GILDD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/GILDD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/GILDD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.3

Neutral momentum band

Price vs 200-day MA

+11.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/GILDD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/GILDD stock rating?

bcba/GILDD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/GILDD analysis?

The full report lives at /stocks/bcba/GILDD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/GILDD?

The latest report frames bcba/GILDD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/GILDD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.